Hailey-Hailey Disease: Case Series and Review of Systemic Medications

Overview

Journal Dermatol Pract Concept

Specialty Dermatology

Date 2024 Aug 9

PMID 39122506

Authors

Kamran Balighi

Zahra Razavi

Maryam Daneshpazhooh

Vahide Lajevardi

Kambiz Kamyab-Hesari

Kimia Ghafouri

Affiliations

Soon will be listed here.

Abstract

Introduction: Hailey-Hailey disease (HHD) is a rare inherited blistering skin disorder characterized by a chronic relapsing course. While it does not pose a serious threat to the patient's health, the quality of life can change. Unfortunately, there is currently no standard treatment for this condition.

Objectives: In this observational retrospective cohort study, our aim was to discover the demographic characteristics and treatment strategies for managing HHD.

Methods: In this retrospective cohort study, we documented the demographic, clinical, and histopathological characteristics beside various treatment employed options of patients diagnosed with HHD at Razi Hospital over the past 14 years.

Results: A total of 32 patients with HHD were enrolled in the study (15 male and 17 female). The mean age of patients was 50.41 ± 13.15 (22-77) years. The average age of disease onset was 37.31 ± 11.88 (15-60) years. Among the participants, 16 individuals (50%) affirm a positive family history of some kind of pemphigoid blisters. The most common site of disease activity was the inguinal area, observed in 14 patients (33.33%). Histopathological examination discovered the existence of suprabasal acantholysis in all of the specimens. Worthily, direct immunofluorescence analysis showed negative results in all skin biopsies. All patients received topical steroids and either topical or systemic antimicrobial agents. In cases of flares, systemic steroids were the most popular and favorable treatment choice during flares.

Conclusion: Indeed, Hailey-Hailey disease, characterized by its chronic inflammatory and rare nature with a relapsing and remitting course, poses a significant challenge for dermatologists. The treatment of HHD has been less than satisfactory and it often presents a challenge and could be misdiagnosed. Among the available treatment options, topical steroids and antimicrobial agents are the most administered therapies.

References

Gisondi P, Sampogna F, Annessi G, Girolomoni G, Abeni D . Severe impairment of quality of life in Hailey-Hailey disease. Acta Derm Venereol. 2005; 85(2):132-5. DOI: 10.1080/00015550410025462. View

Dhitavat J, Fairclough R, Hovnanian A, Burge S . Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease. Br J Dermatol. 2004; 150(5):821-8. DOI: 10.1111/j.1365-2133.2004.05904.x. View

Burge S . Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol. 1992; 126(3):275-82. DOI: 10.1111/j.1365-2133.1992.tb00658.x. View

Hu Z, Bonifas J, Beech J, Bench G, Shigihara T, Ogawa H . Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet. 1999; 24(1):61-5. DOI: 10.1038/71701. View

Farahnik B, Blattner C, Mortazie M, Perry B, Lear W, Elston D . Interventional treatments for Hailey-Hailey disease. J Am Acad Dermatol. 2016; 76(3):551-558.e3. DOI: 10.1016/j.jaad.2016.08.039. View

Dobson-Stone C, Fairclough R, Dunne E, Brown J, Dissanayake M, Munro C . Hailey-Hailey disease: molecular and clinical characterization of novel mutations in the ATP2C1 gene. J Invest Dermatol. 2002; 118(2):338-43. DOI: 10.1046/j.0022-202x.2001.01675.x. View

Rogner D, Lammer J, Zink A, Hamm H . Darier and Hailey-Hailey disease: update 2021. J Dtsch Dermatol Ges. 2021; 19(10):1478-1501. DOI: 10.1111/ddg.14619. View

Arjona-Aguilera C, Jimenez-Gallo D, Villegas-Romero I, Valenzuela-Ubina S, Linares-Barrios M . Subcutaneous methotrexate for Hailey-Hailey disease: two case reports and review of the literature. J Dtsch Dermatol Ges. 2020; 19(2):278-281. DOI: 10.1111/ddg.14198. View

Chiaravalloti A, Payette M . Hailey-Hailey disease and review of management. J Drugs Dermatol. 2015; 13(10):1254-7. View

10.

Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J . Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000; 9(7):1131-40. DOI: 10.1093/hmg/9.7.1131. View

11.

Gottlieb S, LUTZNER M . Hailey-hailey disease--an electron microcopic study. J Invest Dermatol. 1970; 54(5):368-76. DOI: 10.1111/1523-1747.ep12259067. View

12.

Arora H, Bray F, Cervantes J, Falto Aizpurua L . Management of familial benign chronic pemphigus. Clin Cosmet Investig Dermatol. 2016; 9:281-290. PMC: 5027951. DOI: 10.2147/CCID.S89483. View

13.

Poblete-Gutierrez P, Wiederholt T, Konig A, Jugert F, Marquardt Y, Rubben A . Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept. J Clin Invest. 2004; 114(10):1467-74. PMC: 525740. DOI: 10.1172/JCI21791. View

14.

Engin B, Kutlubay Z, Celik U, Serdaroglu S, Tuzun Y . Hailey-Hailey disease: A fold (intertriginous) dermatosis. Clin Dermatol. 2015; 33(4):452-5. DOI: 10.1016/j.clindermatol.2015.04.006. View

15.

Ben Lagha I, Ashack K, Khachemoune A . Hailey-Hailey Disease: An Update Review with a Focus on Treatment Data. Am J Clin Dermatol. 2019; 21(1):49-68. DOI: 10.1007/s40257-019-00477-z. View

16.

Marsch W, STUTTGEN G . Generalized Hailey-Hailey disease. Br J Dermatol. 1978; 99(5):553-60. DOI: 10.1111/j.1365-2133.1978.tb02024.x. View